Just a few weeks ago, Eli Lilly executives cut the ribbon of what they called pharma’s most powerful supercomputer.
On Monday, Roche shared plans to steal that title.
The Swiss drugmaker announced …
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to non-animal alternatives.
Lawmakers on a bipartisan House panel conveyed they are ready to tackle China’s growing dominance in the development of new medicines and the ingredients that
AstraZeneca, Sanofi, AbbVie and Novartis will again face claims that they charged “unlawfully inflated prices” under the 340B drug discount program, after the case was
The FDA will now consider granting its regenerative medicine designations to experimental therapies even if they are on clinical hold, a shift in operating procedures
The FDA unveiled long-awaited draft guidance on how biopharma companies can validate new approaches for toxicology and other early-phase safety studies, potentially reducing the animal
Just a few weeks ago, Eli Lilly executives cut the ribbon of what they called pharma’s most powerful supercomputer.
On Monday, Roche shared plans to steal that title.
The Swiss drugmaker announced …